Skip to main content
Clinical Trials/CTRI/2022/08/044613
CTRI/2022/08/044613
Suspended
未知

A Prospective PlaceboControlled Randomized ClinicalStudy Of Tofacitinib As AnAdjunct to corticosteroids inAcute Severe Ulcerative Colitis

Dr Ajit Sood0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K519- Ulcerative colitis, unspecified
Sponsor
Dr Ajit Sood
Status
Suspended
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Ajit Sood

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with acute severe ulcerative colitis (defined by Truelove
  • Witts Criteria)
  • 2\. Subject must be at least 18 years of age.
  • 3\. Subjects who are willing and able to comply with treatment plan,
  • laboratory tests, daily bowel movement diary call, and other study
  • procedures.
  • 4\. Subjects who are willing to provide a written informed consent.

Exclusion Criteria

  • 1\. Presence of indeterminate colitis, microscopic colitis, ischemic
  • colitis, infectious colitis, or clinical findings suggestive of Crohnâ??s
  • 2\. Subjects displaying clinical signs of fulminant colitis or toxic
  • 3\. Subjects infected with human immunodeficiency virus (HIV) or
  • hepatitis B or C viruses
  • 4\. Subjects who have been vaccinated with live or attenuated vaccine
  • within 6 weeks of baseline or scheduled to receive these vaccines
  • during study period or within 6 weeks after last dose of study
  • 5\. Subjects with malignancies or a history of malignancies, with the
  • exception of adequately treated or excised non\-metastatic basal cell

Outcomes

Primary Outcomes

Not specified

Similar Trials